1.肺癌早期诊断策略探索
Techniques Developing for Early Diagnosis of Lung Cancer
2. 肺癌精准靶向治疗及免疫治疗
Precision Targeted Therapy and Immunotherapy for Lung Cancer
3. 肺癌转化研究及医工交叉研究
Translational and Interdisciplinary Research in Medicine and Engineering of Lung Cancer
4. 小细胞肺癌相关研究
Research on Small Cell Lung Cancer
5. 肺癌相关大数据分析，人工智能及机器学习研究
Application of Big-data Analysis, Artificial Intelligent and Machine Learning in Lung Cancer Research
6. 肺癌多组学研究
Multi-omics Application in Lung Cancer
7. 肺癌可视化研究
Visualization Research on Lung Cancer
同济大学附属上海市肺科医院肿瘤科行政副主任
Deputy Director of Department of Oncology, Tongji University Affiliated Shanghai Pulmonary Hospital
国家重点研发计划青年首席科学家
Young Chief Scientist of National Key Research and Development Program
工信部“揭榜挂帅”项目负责人
Project Leader of Open Bidding for Selecting the Best Candidates Program of Ministry of Industry and Information Technology of China
中国科协高端科技创新青年智库
High end Science and Technology Innovation Youth Think Tank of China Association for Science and Technology
CSCO “35 under 35”最具潜力肿瘤医生
“35 under 35”the Most Promising Oncologist of Chinese Society of Clinical Oncology (CSCO)
上海市银蛇奖
Shanghai Yinshe Award
上海市浦江人才
Shanghai Pujiang Talent
上海市青年拔尖人才
Shanghai Youth Top Talent
上海市曙光学者
Shanghai Shuguang Scholar
上海医树奖青年科技创新奖
Shanghai Medical Science and Technology Innovation Award for Youth
国际肺癌研究协会（IASLC）学者奖
Scholar Award of International Association for the Study of Lung Cancer (IASLC)
国家自然科学基金评审专家
Review Expert of National Natural Science Foundation of China
CSCO研究基金会评审专家
Review Expert of CSCO Research Foundation
《CSCO非小细胞肺癌诊疗指南》指南组成员
Member of CSCO Guideline for Diagnosis and Treatment of Non-small Cell Lung Cancer
CSCO非小细胞肺癌专委会 秘书
Secretary of Expert Committee on Non-small Cell Lung Cancer of CSCO
上海市生物医药行业协会罕见病专委会 副秘书长
Deputy Secretary General of Expert Committee on Rare Disease of Shanghai Biopharmaceutics Industry Association
CSCO青年专家委员会 委员
Member of Youth Expert Committee of CSCO
中国抗癌协会肿瘤药物临床研究专委会 委员
Member of Expert Committee on Clinical Research of Anti-cancer Drug of China Anti-cancer Association
上海市女医师学会肺癌专委会 委员
Member of Expert Committee on Lung Cancer of Shanghai Medical Women’s Association
何雅億，博士，同济大学附属上海市肺科医院主任医师，博士生导师。目前担任同济大学附属上海市肺科医院肿瘤科行政副主任。先后至云南东川人民医院进行扶贫援滇、上海新国博及复兴岛方舱医院新冠救治，美国科罗拉多大学访问学习（PI为国际肺癌研究协会前执行总裁Fred R Hirsch教授）。
Yayi He, PhD./MD., Professor of treatment of Tongji University affiliated Shanghai Pulmonary Hospital, Doctoral supervisor. She is deputy director of Department of Oncology of Tongji University affiliated Shanghai Pulmonary Hospital. She has gone to People’s Hospital of Dongchuan in Yunnan Province for medical aid and participated in fighting against COVID-19. She used to be a visiting scholar in the University of Colorado (the PI was Prof. Fred R Hirsch, the former CEO of the International Association for the Study of Lung Cancer).
何雅億主持了国家重点研发计划、工信部“揭榜挂帅”项目、国家自然科学基金（面上及青年）、省部级项目及横向课题10项，以第一/通讯（含共同）在Nature Cancer、Advanced Science、Journal of Thoracic Oncology、Seminars in Cancer Biology、Journal for Immunotherapy of Cancer、Journal of Hematology & Oncology、Engineering和Acta Pharmaceutica Sinica B等本领域权威期刊发表论文45篇，IF>10的论文15篇，H指数25。参编中英文论著Lung Cancer（副主编，2021）和《肺癌》（副主编，2021）；还参编了《临床研究经典案例分析》（副主编，2021）和《肿瘤靶向治疗及免疫治疗进展》（编委，2020）；应邀参加中国临床肿瘤学年会（CSCO）、美国临床肿瘤学年会（ASCO）、欧洲临床肿瘤学年会（ESMO）、世界肺癌大会（WCLC）和日本肺癌学会年会（JLCS）等学术会议，多次以口头汇报及壁报展示学术成果，获得参会同行的认可。同时，何雅億担任国家自然科学基金委评审专家、CSCO研究基金会评审专家和Translational Lung Cancer Research、《呼吸与危重症医学（英文）》（CMJ PCCM）期刊编委。
Prof. Yayi He has been a leader of 10 projects including National Key Research and Development Program, Open Bidding for Selecting the Best Candidates Program of Ministry of Industry and Information Technology of China, programs from National Natural Science Foundation of China (Youth Program and General Program), provincial and ministerial programs and horizontal topic research. As first and corresponding author (including co-first and co-corresponding author), she has published 45 papers on leading journal in the field including Nature Cancer、Advanced Science、Journal of Thoracic Oncology、Seminars in Cancer Biology、Journal for Immunotherapy of Cancer、Journal of Hematology & Oncology、Engineering and Acta Pharmaceutica Sinica B, of which 15 papers’ impact factors were higher than 10. And the H-score of Prof. Yayi He is 25. She also coedits 4 books including Lung Cancer (subeditor, 2021), Lung Cancer (Chinese version, subeditor, 2021), Classic Case Analysis of Clinical Research (Chinese version, subeditor, 2021) and Advances in Tumor Targeted Therapy and Immunotherapy (Chinese version, editorial board member, 2021). She was invited to do oral presentations or make posters of her studies in Annual Conferences of Chinese Society of Clinical Oncology (CSCO), American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (EMSO), World Conference on Lung Cancer (WCLC) and Japanese Lung Cancer Society (JLCS), which were recognized by the participating peers. At the same time, Prof. He is review expert of National Natural Science Foundation of China and Chinese Society of Clinical Oncology (CSCO) Research Foundation. She is also an editor of Translational Lung Cancer Research and Chinese Medical Journal Pulmonary and Critical Care Medicine.
此外，何雅億作为指南专家组主要秘书参编了2019年《CSCO原发性肺癌诊疗指南》及2020年至2022年《CSCO非小细胞肺癌诊疗指南》；参与了《2019年中国非小细胞肺癌免疫检查点抑制剂治疗专家共识》和《2019年晚期非小细胞肺癌抗血管生成药物治疗中国专家共识》撰写工作。
Furthermore, Prof. Yayi He participated in writing 2019 CSCO Guideline for Diagnosis and Treatment of Primary Lung Cancer and 2020-2022 CSCO Guideline for Diagnosis and Treatment of Non-small Cell Lung Cancer as principal secretary of expert. She also written 2019 Expert Consensus of Immune Checkpoint Blockade Therapy in Lung Cancer and 2019 Expert Consensus of Anti-angiogenesis therapy in Advanced Non-small Cell Lung Cancer.
何雅億先后入选了中国科协高端科技创新青年智库（2021年）、上海市浦江人才（2017年）、上海市青年拔尖人才计划（2019年）、上海市曙光学者（2021年）、上海医树奖青年科技创新奖（2022年）和上海市银蛇奖（2023年）；2015年获得了国际肺癌研究协会（IASLC）学者奖。
Prof. Yayi He has been awarded high-end science and technology innovation youth think tank of China Association for Science and Technology (2021), Shanghai Pujiang Talent (2017), Shanghai Youth Top Talent (2029), Shanghai Shuguang Scholars (2021), Shanghai Medical Science and Technology Innovation Award for Youth (2022), Shanghai Yinshe Award (2023) and Scholar Award of International Association for the Study of Lung Cancer (IASLC) (2015).
